Auto saved by Logseq

pages/STOP2030___Web___Posts.md

@@ -3,7 +3,7 @@
 - # REALISE study registration
 	- ## The design of our REALISE study is now complete, and published
 	- #+BEGIN_VERSE
-	  At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's elimination goals for soil-transmitted helminthiasis (STH). We're happy to announce that we've completed the design of the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), a Phase IV clinical trial aimed at evaluating safety and effectiveness within large populations
+	  At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's elimination goals for soil-transmitted helminthiasis (STH). We're happy to announce that we've completed the design of the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), a clinical trial aimed at evaluating safety and effectiveness within large populations.
 	  
 	  The details of the trial have been published in clinicaltrials.gov and the Pan African Clinical Trial Registry, and are now ready to be delivered to the Institutional Review Boards (IRBs) in Ghana and Kenya, the two countries were it will be carried out.